Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway

Shock

Volumn 46, Issue 3, 2016, Pages 319-328

  Han, Bin ^a   Sheng, Baifa ^a   Zhang, Zhicao ^a   Pu, Aimin ^a   Yin, Jiuheng ^a   Wang, Qimeng ^a   Yang, Kunqiu ^a   Sun, Lihua ^a   Yu, Min ^a   Qiu, Yuan ^a   Xiao, Weidong ^a   Yang, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AhR; intestinal barrier permeability; intestinal epithelial barrier; MLCK MLC phosphorylation signaling; tight junction; tight junction protein

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PROTEIN ZO1; SMALL INTERFERING RNA; 6-FORMYLINDOLO(3,2-B)CARBAZOLE; CARBAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL JUNCTION; CELL PROTECTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; INTESTINE OBSTRUCTION; INTESTINE VILLUS; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; TIGHT JUNCTION; AGONISTS; ANIMAL; C57BL MOUSE; CACO-2 CELL LINE; DISEASE MODEL; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMPEDANCE; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CACO-2 CELLS; CARBAZOLES; DISEASE MODELS, ANIMAL; ELECTRIC IMPEDANCE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTESTINAL OBSTRUCTION; MALE; MICE; MICE, INBRED C57BL; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHORYLATION; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84960193634     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000594     Document Type: Article

References (32)

1. Turner JR: Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9(11):799-809, 2009.
2. Shi XZ, Lin YM, Powell DW, Sarna SK: Pathophysiology of motility dysfunction in bowel obstruction: role of stretch-induced COX-2. Am J Physiol Gastro-intest Liver Physiol 300(1):99-108, 2011.
3. Scharl M, Paul G, Weber A, Jung BC, Docherty MJ, Hausmann M, Rogler G, Barrett KE, McCole DF: Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase N2. Gastroenterology 137(6):2030-2040.e5, 2009.
4. Hammer AM, Khan OM, Morris NL, Li X, Movtchan NV, Cannon AR, Choudhry MA: The effects of alcohol intoxication and burn injury on the expression of claudins and mucins in the small and large intestines. Shock 45(1):73-81, 2016.
5. Carter SR, Zahs A, Palmer JL, Wang L, Ramirez L, Gamelli RL, Kovacs EJ: Intestinal barrier disruption as a cause of mortality in combined radiation and burn injury. Shock 40(4):281-289, 2013.
6. Suzuki T: Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 70(4):631-659, 2013.
7. Su L, Nalle SC, Shen L, Turner ES, Singh G, Breskin LA, Khramtsova EA, Khramtsova G, Tsai PY, Fu YX, et al.: TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 145(2):407-415, 2013.
8. Marchiando AM, Shen L, Graham WV, Edelblum KL, Duckworth CA, Guan Y, Montrose MH, Turner JR, Watson AJ: The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology 140(4):1208-1218, 2011.
9. Cunningham KE, Turner JR: Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci 1258:34-42, 2012.
10. Haarmann-Stemmann T, Bothe H, Abel J: Growth factors, cytokines and their receptors as downstream targets of aryl hydrocarbon receptor(AhR) signaling pathways. Biochem Pharmacol 77(4):508-520, 2009.
11. O'Donnell EF, Koch DC, Bisson WH, Jang HS, Kolluri SK: The aryl hydrocarbon receptor mediates raloxifeneinduced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells. Cell Death Dis 5:e1038, 2014.
12. Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, Biancone L, MacDonald TT, Pallone F, Monteleone G: Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141(1):237-248, 2011.
13. Monteleone I, Pallone F, Monteleone G: Aryl hydrocarbon receptor and colitis. Semin Immunopathol 35(6):671-675, 2013.
14. Sherr DH, Monti S: The role of the aryl hydrocarbon receptor in normal and malignant B cell development. Semin Immunopathol 35(6):705-716, 2013.
15. Wu LL, Chiu HD, Peng WH, Lin BR, Lu KS, Lu YZ, Yu LC: Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta. Crit Care Med 39(9):2087-2098, 2011.
16. Wu LL, Peng WH, Kuo WT, Huang CY, Ni YH, Lu KS, Turner JR, Yu LC: Commensal bacterial endocytosis in epithelial cells is dependent on myosin light chain kinasee activated brush border fanning by interferon-g. Am J Pathol 184(8):2260-2274, 2014.
17. Generoso SV, Viana ML, Santos RG, Arantes RM, Martins FS, Nicoli JR, Machado JA, Correia MI, Cardoso VN: Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. Eur J Nutr 50(4):261-269, 2011.
18. Yang H, Finaly R, Teitelbaum DH: Alteration in epithelial permeability and ion transport in a mouse model of total parenteral nutrition. Crit Care Med 31(4):1118-1125, 2003.
19. Fukumoto S, Toshimitsu T, Matsuoka S, Maruyama A, Oh-Oka K, Takamura T, Nakamura Y, Ishimaru K, Fujii-Kuriyama Y, Ikegami S, et al.: Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis. Immunol Cell Biol 92(5):460-465, 2014.
20. Hiura Y, Satsu H, Hamada M, Shimizu M: Analysis of flavonoids regulating the expression of UGT1A1 via xenobiotic receptors in intestinal epithelial cells. Biofactors 40(3):336-345, 2014.
21. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP: Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control and apoptosis. Biochem Pharmacol 59(1):65-85, 2000.
22. Delescluse C, Lemaire G, de Sousa G, Rahmani R: Is CYP1A1 induction always related to AHR signaling pathway? Toxicology 153(1-3):73-82, 2000.
23. Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR, Raleigh DR, Guan Y, Watson AJ, Montrose MH, et al.: Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 189(1):111-126, 2010.
24. Marchiando AM, Shen L, Graham WV, Edelblum KL, Duckworth CA, Guan Y, Montrose MH, Turner JR, Watson AJ: The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology 140(4):1208-1218, 2011.
25. Xiao G, Yuan F, Geng Y, Qiu X, Liu Z, Lu J, Tang L, Zhang Y, Su L: Eicosapentaenoic acid enhances heatstroke-impaired intestinal epithelial barrier function in rats. Shock 44(4):348-356, 2015.
26. Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L, Turner JR: MLCK-dependent exchange and actin binding regiondependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci USA 107(18):8237-8241, 2010.
27. Wroblewski LE, Shen L, Ogden S, Romero-Gallo J, Lapierre LA, Israel DA, Turner JR, Peek RM Jr: Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology 136(1):236-246, 2009.
28. Henderson LB, Doshi VK, Blackman SM, Naughton KM, Pace RG, Moskovitz J, Knowles MR, Durie PR, Drumm ML, Cutting GR: Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis. PLoS Genet 8(3):e1002580, 2012.
29. de Souza AR, Zago M, Eidelman DH, Hamid Q, Baglole CJ: Aryl hydrocarbon receptor (AhR) attenuation of subchronic cigarette smoke-induced pulmonary neutrophilia is associated with retention of nuclear RelB and suppression of intercellular adhesion molecule-1(ICAM-1). Toxicol Sci 140(1):204-223, 2014.
30. Oberg M, Bergander L, Ha°kansson H, Rannug U, Rannug A: Identification of the tryptophan photoproduct 6-formylindolo[3, 2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol Sci 85(2):935-943, 2005.
31. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR: Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119(Pt 10):2095-2106, 2006.
32. Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C, Turner JR: Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenter-ology 136(2):551-563, 2009.